Journal of Biomedical & Clinical Research, 2015 Since 1994, alcohol septal ablation (ASA) has been used as a minimally invasive treatment of patients with hypertrophic obstructive cardiomyopathy, resistant to conservative medical therapy. This catheter-based intervention consists of injecting absolute
Sotir Marchev, Boyko Kuzmanov
doaj +5 more sources
Septal myectomy after failed septal alcohol ablation. [PDF]
Ann Cardiothorac Surg, 2017 Despite septal myectomy remaining the gold standard septal reduction therapy for hypertrophic obstructive cardiomyopathy (HOCM), there has been a disproportionate use of alcohol septal ablation (ASA) worldwide. Absolute resolution of left ventricular outflow tract (LVOT) obstruction with ASA is not achieved in a substantial proportion of patients.
Quintana E +3 more
europepmc +4 more sources
Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report [PDF]
BMC Cardiovascular Disorders, 2006 Background Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and basal ...
Alioglu Emin +3 more
doaj +4 more sources
Sequential Alcohol Septal Ablation to Resolve LV Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement [PDF]
JACC: Case ReportsLeft ventricular outflow tract obstruction (LVOTO) is a notorious complication of transcatheter mitral valve replacement (TMVR). Computed tomography–derived simulations can predict neo-LVOTO post-TMVR, whereas alcohol septal ablation can mitigate neo ...
Mark M.P. van den Dorpel, MD +9 more
doaj +6 more sources
Alcohol septal ablation – An evolving procedure
Indian Heart Journal, 2012 Alcohol septal ablation was first reported by Sigwart in 1985.1 Since then the use of this procedure has increased exponentially and today the number of alcohol ablations performed far exceed that of surgical myectomy.2 Alcohol septal ablation has been reported from Indian centres since the mid-1990s.3 ...
Ajay Bahl
doaj +3 more sources
Micro-coil embolization for transcatheter septal ablation in a hypertrophic obstructive cardiomyopathy patient and an unusual coronary anatomy: a case report [PDF]
Frontiers in Cardiovascular MedicineBackgroundTranscatheter septal ablation is a minimally invasive therapeutic method for treating symptomatic obstructive hypertrophic cardiomyopathy (HCM).
Aleksandar Mandic +4 more
doaj +2 more sources
Contrast echocardiography with a physiological contrast agent for alcohol septal ablation [PDF]
Frontiers in Cardiovascular MedicinePurposeMyocardial contrast echocardiography in alcohol septal ablation (ASA) is critical prior to alcohol injection into the target septal artery branch.
Erdogan Ilkay +10 more
doaj +2 more sources
Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground The clinical benefits of mavacamten in patients with obstructive hypertrophic cardiomyopathy previously treated with advanced therapies are not established.
Daniele Massera +7 more
doaj +2 more sources
Alternative ‘block and delivery’ approach for alcohol septal ablation in hypertrophic cardiomyopathy with ischemia: a case report [PDF]
The Egyptian Heart JournalBackground Hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder characterized by marked myocardial hypertrophy, which may lead to impaired diastolic function and relative myocardial ischemia.
S. M. Mamun Iqbal +6 more
doaj +2 more sources
Anatolian Journal of Cardiology, 2022 Background: Alcohol septal ablation is recommended for hypertrophic obstructive cardiomyopathy patients who had refractory symptoms despite optimal medical treatment.
Umut Karabulut +5 more
doaj +1 more source